Bvf Partners L P/Il's Net Worth
Bvf Partners L P/Il's net worth is estimated to be at least $502,185,852.70 as of 12/22/2024. CoreStreet's estimation of Bvf Partners L P/Il's net worth is based on their sale of stock and current holding of stock.
Bvf Partners L P/Il is Major Shareholder at Repare Therapeutics Inc. They have executed at least 117 trades of stock as per SEC Form 4 filings. Their most recent trade was for 931,556 units of RPTX stock on 11/15/2023. Their biggest sale was on 07/02/2021 when they sold 2,186,022 units of Merus NV stock for $45,359,956.50. They typically trade 11 times per year.
Total value of insider buys:
- $288,151,884.65
Total value of insider sells:
- $214,033,968.05
Most recent insider trade:
- Nov. 15, 2023
Bvf Partners L P/Il's Insider Trading History
| Repare Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 15, 2023 | Major Shareholder | 931,556 | $5.00 | Buy | $4,657,780.00 |
Nov. 2, 2023 | Major Shareholder | 783,709 | $3.60 | Buy | $2,821,352.40 |
June 13, 2022 | Major Shareholder | 149,161 | $12.73 | Buy | $1,898,819.53 |
| Kymera Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 2, 2023 | Director | 216,406 | $11.64 | Buy | $2,518,965.84 |
Jan. 11, 2023 | Director | 22,110 | $29.89 | Buy | $660,867.90 |
Aug. 22, 2022 | Director | 545,525 | $26.00 | Buy | $14,183,650.00 |
May 26, 2022 | Director | 224,057 | $14.21 | Buy | $3,183,849.97 |
May 20, 2022 | Director | 10,100 | $14.00 | Buy | $141,400.00 |
May 5, 2022 | Director | 150,000 | $19.60 | Buy | $2,940,000.00 |
Jan. 31, 2022 | Director | 34,408 | $40.70 | Buy | $1,400,405.60 |
Jan. 27, 2022 | Director | 95,901 | $38.33 | Buy | $3,675,885.33 |
Jan. 24, 2022 | Director | 272,767 | $37.76 | Buy | $10,299,681.92 |
July 1, 2021 | Director | 544,166 | $47.00 | Buy | $25,575,802.00 |
| Olema Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 12, 2023 | Director | 1,505,932 | $9.84 | Buy | $14,818,370.88 |
June 10, 2022 | Director | 200,000 | $4.03 | Buy | $806,000.00 |
Nov. 30, 2021 | Director | 739,675 | $9.39 | Buy | $6,945,548.25 |
| XOMA Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 5, 2023 | Director | 19,000 | $18.39 | Buy | $349,410.00 |
Sept. 26, 2022 | Director | 6,360 | $16.83 | Buy | $107,038.80 |
Sept. 23, 2022 | Director | 16,600 | $16.50 | Buy | $273,900.00 |
Sept. 16, 2022 | Director | 24,293 | $17.89 | Buy | $434,601.77 |
Sept. 14, 2022 | Director | 26,441 | $17.25 | Buy | $456,107.25 |
March 31, 2021 | Director | 569,797 | $38.36 | Sell | $21,857,412.92 |
Sept. 23, 2020 | Director | 17,089 | $18.20 | Buy | $311,019.80 |
Sept. 21, 2020 | Director | 22,328 | $18.39 | Buy | $410,611.92 |
Sept. 4, 2020 | Director | 7,737 | $18.77 | Buy | $145,223.49 |
Aug. 31, 2020 | Director | 16,005 | $18.48 | Buy | $295,772.40 |
Aug. 28, 2020 | Director | 2,044 | $19.17 | Buy | $39,183.48 |
Aug. 24, 2020 | Director | 11,683 | $19.31 | Buy | $225,598.73 |
Aug. 20, 2020 | Major Shareholder | 1,772 | $19.12 | Buy | $33,880.64 |
Aug. 18, 2020 | Major Shareholder | 895 | $19.27 | Buy | $17,246.65 |
Aug. 14, 2020 | Major Shareholder | 21,922 | $18.69 | Buy | $409,722.18 |
Aug. 12, 2020 | Major Shareholder | 4,050 | $17.34 | Buy | $70,227.00 |
March 25, 2020 | Major Shareholder | 8,264 | $17.20 | Buy | $142,140.80 |
March 13, 2020 | Major Shareholder | 100,000 | $18.34 | Buy | $1,834,000.00 |
Dec. 19, 2019 | Major Shareholder | 373,195 | $22.00 | Buy | $8,210,290.00 |
May 13, 2019 | Major Shareholder | 3,797 | $14.36 | Buy | $54,524.92 |
May 10, 2019 | Major Shareholder | 10,300 | $14.57 | Buy | $150,071.00 |
Dec. 12, 2018 | Major Shareholder | 2,810 | $14.75 | Buy | $41,447.50 |
Dec. 10, 2018 | Major Shareholder | 18,081 | $14.54 | Buy | $262,897.74 |
Dec. 6, 2018 | Major Shareholder | 10,927 | $14.80 | Buy | $161,719.60 |
Dec. 3, 2018 | Major Shareholder | 806 | $14.90 | Buy | $12,009.40 |
Nov. 29, 2018 | Major Shareholder | 10,016 | $14.93 | Buy | $149,538.88 |
Nov. 27, 2018 | Major Shareholder | 11,396 | $15.24 | Buy | $173,675.04 |
Nov. 21, 2018 | Major Shareholder | 25,000 | $15.00 | Buy | $375,000.00 |
Nov. 19, 2018 | Major Shareholder | 9,771 | $13.93 | Buy | $136,110.03 |
Nov. 15, 2018 | Major Shareholder | 21,141 | $13.31 | Buy | $281,386.71 |
| XOMA Corporation | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 5, 2023 | Director | 19,000 | $18.39 | Buy | $349,410.00 |
Sept. 26, 2022 | Director | 6,360 | $16.83 | Buy | $107,038.80 |
Sept. 23, 2022 | Director | 16,600 | $16.50 | Buy | $273,900.00 |
Sept. 16, 2022 | Director | 24,293 | $17.89 | Buy | $434,601.77 |
Sept. 14, 2022 | Director | 26,441 | $17.25 | Buy | $456,107.25 |
| Third Harmonic Bio Inc. | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 20, 2022 | Major Shareholder | 214,063 | $4.11 | Buy | $879,798.93 |
| Rain Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 8, 2022 | Insider | 1,710,358 | $5.83 | Buy | $9,971,387.14 |
Sept. 13, 2021 | Director | 392,269 | $16.49 | Buy | $6,468,515.81 |
July 6, 2021 | Director | 269,723 | $15.25 | Buy | $4,113,275.75 |
July 1, 2021 | Director | 317,279 | $15.65 | Buy | $4,965,416.35 |
May 24, 2021 | Director | 1,361 | $15.90 | Buy | $21,639.90 |
May 21, 2021 | Director | 121,986 | $15.94 | Buy | $1,944,456.84 |
May 13, 2021 | Director | 58,000 | $14.26 | Buy | $827,080.00 |
| CTi Biopharma Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 9, 2022 | Director | 7,210,566 | $6.12 | Sell | $44,128,663.92 |
April 1, 2021 | Director | 2,000,000 | $2.50 | Buy | $5,000,000.00 |
Feb. 9, 2018 | Major Shareholder | 5,634,108 | $3.00 | Buy | $16,902,324.00 |
| Cullinan Oncology LLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 1, 2022 | Major Shareholder | 751,396 | $11.00 | Buy | $8,265,356.00 |
April 1, 2022 | Major Shareholder | 276,000 | $10.75 | Buy | $2,967,000.00 |
| Merus NV | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 7, 2021 | Major Shareholder | 985,447 | $27.53 | Sell | $27,129,355.91 |
July 2, 2021 | Major Shareholder | 2,186,022 | $20.75 | Sell | $45,359,956.50 |
March 22, 2021 | Major Shareholder | 79,500 | $22.75 | Buy | $1,808,625.00 |
March 16, 2021 | Major Shareholder | 250,000 | $23.00 | Buy | $5,750,000.00 |
Jan. 21, 2021 | Major Shareholder | 844,680 | $24.75 | Buy | $20,905,830.00 |
Dec. 18, 2020 | Major Shareholder | 160,000 | $16.05 | Buy | $2,568,000.00 |
Sept. 15, 2020 | Major Shareholder | 146,754 | $11.75 | Buy | $1,724,359.50 |
Sept. 10, 2020 | Major Shareholder | 189,651 | $11.10 | Buy | $2,105,126.10 |
Sept. 3, 2020 | Major Shareholder | 201,906 | $11.17 | Buy | $2,255,290.02 |
June 8, 2020 | Major Shareholder | 87,254 | $15.20 | Buy | $1,326,260.80 |
June 1, 2020 | Major Shareholder | 1,462,510 | $14.00 | Buy | $20,475,140.00 |
Jan. 16, 2020 | Major Shareholder | 278,730 | $16.15 | Buy | $4,501,489.50 |
| Infinity Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 22, 2021 | Major Shareholder | 5,848,520 | $4.14 | Sell | $24,212,872.80 |
Nov. 19, 2018 | Major Shareholder | 1,465,126 | $1.37 | Buy | $2,007,222.62 |
Nov. 15, 2018 | Major Shareholder | 91,474 | $1.35 | Buy | $123,489.90 |
Nov. 13, 2018 | Major Shareholder | 604,208 | $1.35 | Buy | $815,680.80 |
June 21, 2018 | Major Shareholder | 425,531 | $1.65 | Buy | $702,126.15 |
June 19, 2018 | Major Shareholder | 3,516,560 | $1.65 | Buy | $5,802,324.00 |
| Cytokinetics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 9, 2020 | Insider | 430,954 | $18.00 | Sell | $7,757,172.00 |
Feb. 13, 2020 | Major Shareholder | 1,072,030 | $15.79 | Sell | $16,927,353.70 |
Dec. 10, 2019 | Major Shareholder | 223,659 | $9.40 | Buy | $2,102,394.60 |
| GlycoMimetics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 4, 2020 | Major Shareholder | 1,266,737 | $2.60 | Buy | $3,293,516.20 |
Oct. 30, 2020 | Major Shareholder | 932,612 | $2.75 | Buy | $2,564,683.00 |
Sept. 5, 2019 | Major Shareholder | 1,668,746 | $3.18 | Buy | $5,306,612.28 |
| Ideaya Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 30, 2020 | Major Shareholder | 2,531 | $13.32 | Buy | $33,712.92 |
June 22, 2020 | Major Shareholder | 19,732 | $13.93 | Buy | $274,866.76 |
June 19, 2020 | Major Shareholder | 98,264 | $14.39 | Buy | $1,414,018.96 |
| Calithera Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 21, 2020 | Major Shareholder | 2,283,598 | $6.00 | Sell | $13,701,588.00 |
Nov. 20, 2019 | Major Shareholder | 191,954 | $3.91 | Buy | $750,540.14 |
Nov. 14, 2019 | Major Shareholder | 128,488 | $3.37 | Buy | $433,004.56 |
Oct. 29, 2019 | Major Shareholder | 1,598,977 | $2.60 | Buy | $4,157,340.20 |
| Pieris Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 6, 2019 | Major Shareholder | 50,000 | $4.50 | Sell | $225,000.00 |
| Concert Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 10, 2019 | Major Shareholder | 386,289 | $10.70 | Sell | $4,133,292.30 |
| Xenon Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 15, 2017 | Major Shareholder | 18,858 | $2.41 | Buy | $45,447.78 |
Aug. 14, 2017 | Major Shareholder | 41,344 | $2.70 | Buy | $111,628.80 |
| Alpine Immune Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 7, 2017 | Major Shareholder | 36,900 | $2.28 | Buy | $84,132.00 |
June 5, 2017 | Major Shareholder | 35,750 | $2.29 | Buy | $81,867.50 |
| ChemoCentryx Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 10, 2015 | Major Shareholder | 955,700 | $9.00 | Sell | $8,601,300.00 |
Dec. 5, 2013 | Major Shareholder | 189,800 | $5.01 | Buy | $950,898.00 |
Nov. 6, 2013 | Major Shareholder | 136,066 | $4.92 | Buy | $669,444.72 |
Nov. 1, 2013 | Major Shareholder | 336,225 | $4.99 | Buy | $1,677,762.75 |
Oct. 9, 2013 | Major Shareholder | 1,289,354 | $5.34 | Buy | $6,885,150.36 |
Oct. 3, 2013 | Major Shareholder | 109,425 | $5.49 | Buy | $600,743.25 |
Sept. 13, 2013 | Major Shareholder | 325,635 | $5.95 | Buy | $1,937,528.25 |
Nov. 6, 2012 | Major Shareholder | 40,000 | $12.00 | Buy | $480,000.00 |
| Rigel Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 7, 2013 | Major Shareholder | 32,700 | $3.47 | Buy | $113,469.00 |
| Ligand Pharmaceuticals Incorporated | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 23, 2013 | Major Shareholder | 39,600 | $19.78 | Buy | $783,288.00 |
Dec. 14, 2012 | Major Shareholder | 5,386 | $18.63 | Buy | $100,341.18 |
Dec. 6, 2012 | Major Shareholder | 50,100 | $17.94 | Buy | $898,794.00 |
Oct. 31, 2012 | Major Shareholder | 16,591 | $15.19 | Buy | $252,017.29 |
| Catalyst Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 16, 2012 | Major Shareholder | 595,000 | $4.00 | Buy | $2,380,000.00 |
Nov. 8, 2012 | Major Shareholder | 72,429 | $4.03 | Buy | $291,888.87 |
Nov. 2, 2012 | Major Shareholder | 139,700 | $4.05 | Buy | $565,785.00 |